Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease
- 1 January 1991
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 41 (5) , 493-494
- https://doi.org/10.1007/bf00626377
Abstract
Five patients with Parkinson's disease were given a single sublingual dose of apomorphine in 3 mg tablets (2 patients received 18 mg and 3 patients took 39 mg).Keywords
This publication has 8 references indexed in Scilit:
- Efficacy of sublingual apomorphine in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- SUBCUTANEOUS APOMORPHINE ADMINISTRATION IN PARKINSONIAN MOTOR FLUCTUATIONS1990
- Sublingual apomorphine and Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988
- Determination of apomorphine in rat plasma and brain by high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Onset and End-of-Dose Levodopa-Induced DyskinesiasArchives of Neurology, 1978
- Treatment of Parkinson's Disease with AporphinesNew England Journal of Medicine, 1976